Faeth Therapeutics, Inc <FTH.O>: Raymond James initiates coverage with outperform rating; price target $56
FTH•Related News
Co-Diagnostics holders exercise 1,702,362 warrants at USD 1.57 per share in inducement deal
CODX•
Replimune Group Inc <REPL.O>: Piper Sandler Raises to Overweight From Neutral; Raises Target Price to $14 From $9
REPL•
US Treasury yield curve 'twist' reflects view Fed may not hike again
TLT•
PAVmed to host business update call, report Q2 2026 results
PAVM•
Barfresh Food Group schedules Q2 results conference call
BRFH•